Literature DB >> 20131104

Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer.

Hiroki Kato, Katsura Kohata, Joji Yamamoto, Satoshi Ichikawa, Mika Watanabe, Kenichi Ishizawa, Ryo Ichinohasama, Hideo Harigae.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20131104     DOI： 10.1007/s12185-010-0491-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit.

Authors:  J Plumas; V Gruart; D Aldebert; M J Truong; M Capron; A Capron; L Prin
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

2.  Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF.

Authors:  George K Anagnostopoulos; George H Sakorafas; Panagiotis Kostopoulos; George Margantinis; Stavros Tsiakos; Evaggelos Terpos; George Pavlakis; Paul Fortun; Dimitrios Arvanitidis
Journal:  J Surg Oncol       Date:  2005-03-15       Impact factor: 3.454

3.  Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.

Authors:  L Prin; J Plumas; V Gruart; S Loiseau; D Aldebert; J C Ameisen; A Vermersch; P Fenaux; O Bletry; M Capron
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

Review 4.  Eosinophilia.

Authors:  M E Rothenberg
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

5.  Unusual hemangioendothelioma of the liver with epithelioid morphology associated with marked eosinophilia: autopsy case.

Authors:  Tokuhiro Kimura; Makio Mukai; Yuko Kaneko; Michito Hirakata; Shinichiro Okamoto; Michiie Sakamoto; Yasunori Okada; Yasuo Ikeda
Journal:  Pathol Int       Date:  2006-11       Impact factor: 2.534

Review 6.  Diagnosis and treatment of hypereosinophilic syndromes.

Authors:  Sarah Fletcher; Barbara Bain
Journal:  Curr Opin Hematol       Date:  2007-01       Impact factor: 3.284

7.  Sudden death of a patient with primary hypereosinophilia, colon tumours, and pulmonary emboli.

Authors:  K Uemura; M Nakajima; N Yamauchi; M Fukayama; K Yoshida
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 8.  Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Authors:  J Gotlib; J Cools
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

Review 9.  Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.

Authors:  Peter Valent
Journal:  Blood Rev       Date:  2009-02-25       Impact factor: 8.250

10.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.

Authors:  P D Collins; S Marleau; D A Griffiths-Johnson; P J Jose; T J Williams
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307
View more
  4 in total

1.  Impact of chemotherapy on eosinophilia-associated advanced rectal cancer: A case report and review of the literature.

Authors:  Maki Inoue; Jun Kadono; Hiroshi Sugita; Toshihiro Nakazono; Shunsuke Motoi; Iwao Kitazono; Yuko Goto; Yoshihiko Fukukura; Makoto Yoshimitsu; Takaharu Misaka; Yutaka Imoto
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

2.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

3.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

4.  Eosinophilic peritonitis with colon cancer: a case report.

Authors:  Ryo Ataka; Hirokazu Tanaka; Shintaro Yagi; Kei Yamane; Kenji Yoshino; Tomoyuki Miyauchi; Tomoaki Yoh; Keiichi Arafuka; Shinichi Fujita; Akihiko Hamada; Bunji Endo; Shinji Uemoto
Journal:  BMC Gastroenterol       Date:  2020-10-27       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.